Decreased serum amyloid β1–42 autoantibody levels in Alzheimer’s disease, determined by a newly developed immuno-precipitation assay with radiolabeled amyloid β1–42 peptide

✍ Scribed by Sylvia Brettschneider; Nils G. Morgenthaler; Stefan J. Teipel; Christina Fischer-Schulz; Katharina Bürger; Richard Dodel; Yansheng Du; Hans-Jürgen Möller; Andreas Bergmann; Harald Hampel

• Book ID: 119196648
• Publisher: Elsevier Science
• Year: 2005
• Tongue: English
• Weight: 181 KB
• Volume: 57
• Category: Article
• ISSN: 0006-3223
• DOI: 10.1016/j.biopsych.2004.12.008